The IBA57 gene helps mitochondria, the parts of cells that make energy, build small iron sulfur tools that many proteins need to work. If this gene does not work properly, cells can struggle to make enough energy, especially in the brain and muscles. Harmful variants in both copies of the IBA57 gene can cause an inherited mitochondrial condition with developmental delay, low muscle tone, movement changes, and other neurologic problems. This gene is mainly known in medical genetics rather than in popular culture.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions for making molecules or directing processes in the body. Some genes hold the information needed to make proteins, the parts of cells that do much of the work. Other genes are mainly involved in regulating when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. If you want to look into this topic more closely, you can find more in the LearnHub.
Overview
IBA57Gene function
What if the gene works
The IBA57 gene helps mitochondria, your cells’ energy centers, make small iron-sulfur parts that many proteins need. This supports energy production and the normal work of several cell enzymes.
Risk
What if the gene does not work
Variants in the IBA57 gene can disrupt mitochondrial energy production and cause a rare condition affecting the brain and movement. Milder and more severe variants can change whether problems mainly involve spasticity or earlier, broader developmental difficulties.
Treatment
What does that mean for your treatment
For pathogenic variants in the IBA57 gene, no gene-specific treatment or drug selection approach is currently established; care is supportive and guided by the person’s symptoms. The IBA57 gene is being studied in mitochondrial disease research, but this has not yet led to a targeted therapy used in clinical guidelines.
Conditions associated with IBA57
Gene function
What if the gene works
Your cells need steady energy to power muscles, nerves, and organs. The IBA57 gene helps mitochondria, the parts of cells that make energy, prepare small iron-containing parts that many proteins need. Understanding what the IBA57 gene does in the body helps explain how cells keep routine energy work running.
Inside mitochondria, IBA57 helps finish making certain iron-sulfur clusters (tiny iron-containing parts that help proteins work). It supports a later assembly step so selected proteins can receive these working parts.
These iron-sulfur parts are needed by several mitochondrial enzymes before they can do their jobs. IBA57 helps prepare that final setup, allowing those enzymes to take part in everyday cell chemistry.
Many of the enzymes supported by IBA57 are involved in how cells turn food into usable energy. This links the IBA57 gene to normal day-to-day mitochondrial energy production.
What is a variant?
A genetic variant is a small change in a gene’s DNA sequence. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IBA57 gene can make the protein unstable, shorter, or misshapen, which may disrupt iron sulfur clusters, small parts many cell proteins rely on. Some missense variants leave partial activity. More disruptive variants, including ones that cut the protein short, can leave little or no working protein. These variants in the IBA57 gene are often linked to earlier and more severe multiple mitochondrial dysfunctions syndrome 3.
How variants are linked to conditions
Pathogenic variants in both copies of the IBA57 gene cause multiple mitochondrial dysfunctions syndrome 3, a rare inherited condition usually diagnosed in infancy or early childhood. In medical genetics, conditions linked to the IBA57 gene include severe developmental delay, low muscle tone, seizures, feeding difficulties, and characteristic brain imaging changes. Some people with IBA57-related disease have a milder presentation, with features such as spasticity, movement problems, or optic nerve involvement.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and instead reflect normal human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, one well characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For IBA57, risk is mainly determined by inheritance: it rises when both parents carry a harmful IBA57 change and a child inherits both altered copies. There is not enough evidence that diet, exercise, or other lifestyle factors lower the chance of developing an IBA57-related condition.
Inheritance of IBA57 variants
Variants in the IBA57 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two altered copies of the IBA57 gene, one from each parent, to have an IBA57-related condition. Parents who carry one altered copy are usually called carriers and often do not have symptoms. For each pregnancy between two carriers, there is a 25% chance the child will inherit both altered copies, a 50% chance the child will be a carrier, and a 25% chance the child will inherit neither altered copy.
What does my IBA57 result mean for my family?
For families with an IBA57-related condition, this usually follows a recessive pattern. That means parents are often healthy carriers, brothers and sisters may also have the condition or be carriers, and other relatives could be carriers too. Children of someone with an IBA57-related condition will usually be carriers unless the other parent also carries an IBA57 variant.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the IBA57 gene, doctors use genetic testing for IBA57 variants on a blood or saliva sample. A lab reads the gene’s DNA sequence and checks for variants that may explain a person’s symptoms. Results can show a pathogenic variant, a benign change, or a variant of uncertain significance.
When should I consider getting a genetic test?
Genetic testing for the IBA57 gene may be considered when a baby or child has signs of a rare inherited condition that affects the body’s energy supply, such as severe developmental delay, weak muscle tone, feeding problems, or vision or nerve changes. It can also help if there is a family history of this condition or a known IBA57 variant.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, seems weaker for another, or causes more side effects in someone else. Part of the reason is that the body can absorb, break down, transport, or respond to a drug differently based on inherited differences. These differences are common and can influence both how well a medicine works and how sensitive a person may be to it.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. By studying the relationship between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the IBA57 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so any medication side effects, treatment questions, or new health concerns are best discussed with your doctor.
History
In recent decades, researchers began exploring how the IBA57 gene works as part of broader efforts to understand mitochondrial disease. Interest grew after studies in yeast identified related genes involved in building iron sulfur parts that cells need, which helped guide work in humans. Building on this early work, scientists linked changes in the IBA57 gene to a rare inherited mitochondrial condition in the early 2010s. That connection helped explain why some affected children shared patterns such as developmental changes, weakness, and brain findings on scans. Over time, descriptions became more precise as additional families were reported and the gene’s role in disease became clearer. These historical steps shaped today’s understanding of IBA57 as an established cause of a specific mitochondrial condition.